2022 Q3 Form 10-Q Financial Statement

#000109181822000108 Filed on August 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $489.7K $538.1K $470.6K
YoY Change 12.99% 30.02% 11.33%
Cost Of Revenue $86.06K $89.94K $65.90K
YoY Change 25.23% 38.84% -10.3%
Gross Profit $403.6K $448.2K $404.7K
YoY Change 10.68% 28.38% 15.88%
Gross Profit Margin 82.42% 83.29% 86.0%
Selling, General & Admin $272.6K $281.1K $251.0K
YoY Change 11.9% 10.79% 5.46%
% of Gross Profit 67.54% 62.73% 62.02%
Research & Development $61.72K $46.92K $47.02K
YoY Change 25.83% -2.82% 18.92%
% of Gross Profit 15.29% 10.47% 11.62%
Depreciation & Amortization $1.000K $959.00 $960.00
YoY Change 40.85% 84.07% 113.33%
% of Gross Profit 0.25% 0.21% 0.24%
Operating Expenses $335.3K $329.0K $299.0K
YoY Change 14.3% 8.75% 7.55%
Operating Profit $68.30K $119.2K $105.8K
YoY Change -4.23% 155.99% 48.38%
Interest Expense -$130.00 -$130.00 -$100.00
YoY Change -51.85% -150.0%
% of Operating Profit -0.19% -0.11% -0.09%
Other Income/Expense, Net $47.66K -$101.00
YoY Change 154.94% -32.67%
Pretax Income $68.17K $166.8K $105.7K
YoY Change -63.99% 155.69% 48.57%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $57.83K $166.8K $105.7K
YoY Change -69.45% 155.69% 48.57%
Net Earnings / Revenue 11.81% 31.0% 22.45%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $96.47 $0.00 $462.70
COMMON SHARES
Basic Shares Outstanding 228.1M shares 228.1M shares 228.6M shares
Diluted Shares Outstanding 599.5M shares 599.7M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $468.2K $227.1K $383.8K
YoY Change 16.75% -24.84% 264.84%
Cash & Equivalents $468.2K $227.0K $383.8K
Short-Term Investments
Other Short-Term Assets $53.61K $26.73K $36.04K
YoY Change 13.15% -69.82% -28.82%
Inventory $21.10K $13.09K $19.25K
Prepaid Expenses $15.36K
Receivables $538.0K $460.9K $290.8K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.081M $727.8K $729.9K
YoY Change 38.0% 15.52% 112.23%
LONG-TERM ASSETS
Property, Plant & Equipment $15.14K $13.72K $14.68K
YoY Change 32.93% 51.19% 94.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $68.44K $67.02K $67.97K
YoY Change 21.8% 123.1% 182.97%
TOTAL ASSETS
Total Short-Term Assets $1.081M $727.8K $729.9K
Total Long-Term Assets $68.44K $67.02K $67.97K
Total Assets $1.149M $794.8K $797.9K
YoY Change 36.91% 20.42% 116.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $75.22K $115.9K $153.0K
YoY Change -52.97% -41.55% -33.98%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.087M $790.7K $939.8K
YoY Change -4.38% -31.9% 0.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $113.3K $123.6K $144.4K
YoY Change -26.67% 1626.26% 2087.88%
Total Long-Term Liabilities $113.3K $123.6K $144.4K
YoY Change -26.67% 8.53% 27.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.087M $790.7K $939.8K
Total Long-Term Liabilities $113.3K $123.6K $144.4K
Total Liabilities $1.201M $914.3K $1.084M
YoY Change -7.05% -28.29% 3.44%
SHAREHOLDERS EQUITY
Retained Earnings -$15.29M -$15.36M
YoY Change -2.55% -3.29%
Common Stock $2.281K $2.281K
YoY Change -0.22% 0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$51.38K -$119.6K -$286.4K
YoY Change
Total Liabilities & Shareholders Equity $1.149M $794.8K $797.9K
YoY Change 36.91% 20.42% 116.85%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $57.83K $166.8K $105.7K
YoY Change -69.45% 155.69% 48.57%
Depreciation, Depletion And Amortization $1.000K $959.00 $960.00
YoY Change 40.85% 84.07% 113.33%
Cash From Operating Activities $243.6K -$156.7K $5.680K
YoY Change 138.94% -178.77% -92.86%
INVESTING ACTIVITIES
Capital Expenditures -$2.420K $0.00 $0.00
YoY Change -19.87% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.420K $0.00 $0.00
YoY Change -19.87% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 243.6K -156.7K 5.680K
Cash From Investing Activities -2.420K 0.000 0.000
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash 241.1K -156.7K 5.680K
YoY Change 143.79% -179.59% -87.85%
FREE CASH FLOW
Cash From Operating Activities $243.6K -$156.7K $5.680K
Capital Expenditures -$2.420K $0.00 $0.00
Free Cash Flow $246.0K -$156.7K $5.680K
YoY Change 134.37% -177.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Cleartronic, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0958798
dei Entity Address Address Line1
EntityAddressAddressLine1
8000 North Federal Highway
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33487
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock Par Value $0.00001
dei Trading Symbol
TradingSymbol
CLRI
dei Security Exchange Name
SecurityExchangeName
NONE
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
228120695 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
227045 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
401001 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
460895 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
320245 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
13089 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
14653 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26725 usd
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47383 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
727754 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
783282 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13716 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11391 usd
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
53302 usd
CY2021Q3 us-gaap Due From Related Parties
DueFromRelatedParties
44801 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
53302 usd
CY2021Q3 us-gaap Other Assets
OtherAssets
44801 usd
CY2022Q2 us-gaap Assets
Assets
794772 usd
CY2021Q3 us-gaap Assets
Assets
839474 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
115847 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
159952 usd
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
674876 usd
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
977296 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
790723 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1137248 usd
CY2022Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
123600 usd
CY2021Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
154500 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
123600 usd
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
154500 usd
CY2022Q2 us-gaap Liabilities
Liabilities
914323 usd
CY2021Q3 us-gaap Liabilities
Liabilities
1291748 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228120695 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228120695 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228578995 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228578995 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2281 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2286 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240112 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240107 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15362020 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15694743 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-119551 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-452274 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
794772 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
839474 usd
CY2022Q2 us-gaap Revenues
Revenues
538102 usd
CY2021Q2 us-gaap Revenues
Revenues
413868 usd
us-gaap Revenues
Revenues
1527910 usd
us-gaap Revenues
Revenues
1217928 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
89938 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
64777 usd
us-gaap Cost Of Revenue
CostOfRevenue
248074 usd
us-gaap Cost Of Revenue
CostOfRevenue
198580 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
448164 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
349091 usd
us-gaap Gross Profit
GrossProfit
1279836 usd
us-gaap Gross Profit
GrossProfit
1019348 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
173822 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
147483 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
498232 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
417614 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
107299 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106253 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
350339 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
327336 usd
CY2022Q2 us-gaap Depreciation
Depreciation
959 usd
CY2021Q2 us-gaap Depreciation
Depreciation
521 usd
us-gaap Depreciation
Depreciation
2733 usd
us-gaap Depreciation
Depreciation
1423 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46923 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48285 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143199 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118612 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
329003 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
302542 usd
us-gaap Operating Expenses
OperatingExpenses
994503 usd
us-gaap Operating Expenses
OperatingExpenses
864985 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
47792 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
18430 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
47792 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
18430 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-133 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
264 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-402 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1004 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47659 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18694 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47390 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17426 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
166820 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65243 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
332723 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
171789 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
166820 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
65243 usd
us-gaap Net Income Loss
NetIncomeLoss
332723 usd
us-gaap Net Income Loss
NetIncomeLoss
171789 usd
CY2022Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10232 usd
CY2021Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10119 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
30695 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
30584 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
156588 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
55124 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
302028 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
141205 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228120695 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226602935 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228280177 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224997827 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600815630 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599641812 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599210522 shares
us-gaap Net Income Loss
NetIncomeLoss
332723 usd
us-gaap Net Income Loss
NetIncomeLoss
171789 usd
us-gaap Depreciation
Depreciation
2733 usd
us-gaap Depreciation
Depreciation
1423 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
47792 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
18430 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
148650 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9470 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1564 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1309 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-20658 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3687 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-36729 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-43457 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-333320 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
241959 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-168898 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
49152 usd
clri Increase Decrease In Due From Related Parties Non Current
IncreaseDecreaseInDueFromRelatedPartiesNonCurrent
8501 usd
clri Increase Decrease In Due From Related Parties Non Current
IncreaseDecreaseInDueFromRelatedPartiesNonCurrent
7548 usd
CY2021Q3 us-gaap Deferred Subscriber Acquisition Costs Current
DeferredSubscriberAcquisitionCostsCurrent
41283 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
276634 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5058 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2068 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5058 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2068 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
48447 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-48447 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-173956 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
226119 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
401001 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
75983 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
227045 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
302102 usd
us-gaap Interest Paid Net
InterestPaidNet
402 usd
us-gaap Interest Paid Net
InterestPaidNet
2754 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
690 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-452274 usd
us-gaap Profit Loss
ProfitLoss
332723 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-119551 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-286371 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
166820 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-119551 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-786796 usd
us-gaap Profit Loss
ProfitLoss
171789 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-615007 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-680250 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
65243 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-615007 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
156588 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
55124 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228120695 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226602935 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
302028 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
141205 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228280177 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224997827 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin:0pt"><b>USE OF ESTIMATES</b></p><p style="margin:0pt"> </p><p style="margin:0pt">In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period.</p><p style="margin:0pt"> </p><p style="margin:0pt">Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. </p><p style="margin:0pt"> </p><p style="margin:0pt">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for doubtful accounts.</p>
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18000 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin:0pt"><b>CONCENTRATION OF CREDIT RISK </b></p><p style="margin:0pt"> </p><p style="margin:0pt">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts are insured up to a maximum of $250,000 at all FDIC-insured institutions. As of June 30, 2022 and September 30, 2021, the Company had $0 and $139,577, respectively, in excess of FDIC insurance limits.</p><p style="margin:0pt"> </p>
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
clri Amount Of Fdic Insurance Limits
AmountOfFdicInsuranceLimits
0 usd
CY2021 clri Amount Of Fdic Insurance Limits
AmountOfFdicInsuranceLimits
139577 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143199 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118612 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46923 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48285 usd
CY2022Q2 us-gaap Deferred Subscriber Acquisition Costs Current
DeferredSubscriberAcquisitionCostsCurrent
0 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
156588 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
55124 usd
CY2022Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10232 usd
CY2021Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10119 usd
CY2022Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
166820 usd
CY2021Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
65243 usd
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
228120695 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
226602935 shares
CY2022Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
371361635 shares
CY2021Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
374212695 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600815630 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
302028 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
141205 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
30695 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
30584 usd
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
332723 usd
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
171789 usd
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
228280177 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
224997827 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
371361635 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
374212695 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599641812 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599210522 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Advertising Expense
AdvertisingExpense
33044 usd
us-gaap Advertising Expense
AdvertisingExpense
12583 usd
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
21223 usd
CY2021Q2 us-gaap Advertising Expense
AdvertisingExpense
3877 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19180 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14122 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5464 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2731 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13716 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11391 usd
CY2022Q2 us-gaap Depreciation
Depreciation
959 usd
CY2021Q2 us-gaap Depreciation
Depreciation
521 usd
us-gaap Depreciation
Depreciation
2733 usd
us-gaap Depreciation
Depreciation
1423 usd
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
19944 usd
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
13428 usd
CY2022Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
7029 usd
CY2021Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
4473 usd
CY2021Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
2000 sqft
CY2021Q4 clri Monthly Rental Cost
MonthlyRentalCost
2200 usd
CY2021Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-11-30
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
19944 usd
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
13428 usd
CY2022Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
7029 usd
CY2021Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
4473 usd
us-gaap Royalty Expense
RoyaltyExpense
4000 usd
us-gaap Royalty Expense
RoyaltyExpense
8953 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001362516
dei Entity File Number
EntityFileNumber
000-55329

Files In Submission

Name View Source Status
0001091818-22-000108-index-headers.html Edgar Link pending
0001091818-22-000108-index.html Edgar Link pending
0001091818-22-000108.txt Edgar Link pending
0001091818-22-000108-xbrl.zip Edgar Link pending
clri-20220630.htm.htm Edgar Link pending
clri-20220630.xsd Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
clri-20220630_cal.xml Edgar Link unprocessable
clri-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clri-20220630_pre.xml Edgar Link unprocessable
clri-20220630.htm_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clri-20220630_def.xml Edgar Link unprocessable